Minocin - (100 mg/vial ; Injection)

Generic Name	Minocycline Hydrochloride	Innovator	Milinta (Rempex)
Dosage	100 mg/vial ; Injection	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	None	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	None
Indication	To reduce the development of drug-resistant bacteria and maintain the effectiveness of MINOCIN® (minocycline) for Injection and other antibacterial drugs, MINOCIN® (minocycline) for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
***** ******	*** \ ***	*** **, ****	*******	********	****** *** **, ****

Chronology Of Events